M.D. ANDERSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

3-Dimensional Form and Soft Tissue Biomechanics of the Breast

Terminated

Conditions: Breast Cancer

Interventions: Procedure: 3-D Optical Surface Scan
Procedure: Mechanical Testing
Procedure: Cutaneous Ultrasound
Procedure: Breast MRI and/or CT

First Posted Date: 2007-07-18

Last Posted Date: 2012-02-22

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 45

Registration Number: NCT00502814

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Busulfan and Fludarabine in Patients With AML and MDS

Phase 2

Completed

Conditions: Leukemia

Interventions: Drug: Busulfan
Drug: Fludarabine

First Posted Date: 2007-07-18

Last Posted Date: 2012-05-28

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 200

Registration Number: NCT00502905

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Quality of Life Study for Pediatric and Adult Patients Undergoing Hyperthermic Peritoneal Perfusion With Cisplatin

Completed

Conditions: Peritoneal Neoplasms

Interventions: Behavioral: Questionnaire

First Posted Date: 2007-07-17

Last Posted Date: 2018-10-24

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 48

Registration Number: NCT00502177

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

In Vivo Confocal Imaging of Oral Mucosa

Completed

Conditions: Oral Tumors

Interventions: Procedure: Reflectance Confocal Imaging

First Posted Date: 2007-07-17

Last Posted Date: 2012-08-01

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 12

Registration Number: NCT00502125

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Evaluation of a Multispectral Vision Enhancement System for Assessment of Oral Mucosal Lesions

Completed

Conditions: Oral Cancer

Interventions: Behavioral: Interview

First Posted Date: 2007-07-17

Last Posted Date: 2012-07-30

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 45

Registration Number: NCT00502580

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus

Phase 2

Completed

Conditions: Mixed Tumor, Mullerian

Interventions: Drug: Carboplatin
Drug: Paclitaxel

First Posted Date: 2007-07-17

Last Posted Date: 2016-05-09

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 23

Registration Number: NCT00502203

Locations: 🇺🇸
Lyndon Baines Johnson Hospital, Houston, Texas, United States
🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸
Loma Linda Cancer Institute, Loma Linda, California, United States

and more 1 locations

Post-Operative Chemoradiation for Extremity & Trunk Soft Tissue Sarcoma

Phase 1

Completed

Conditions: Soft Tissue Sarcoma

Interventions: Drug: Doxorubicin
Radiation: Radiation Therapy

First Posted Date: 2007-07-17

Last Posted Date: 2015-11-18

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 4

Registration Number: NCT00502411

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients

Completed

Conditions: Lung Cancer
Colorectal Cancer
Anal Cancer
Esophageal Cancer
Gastric Cancer

Interventions: Behavioral: Questionnaire

First Posted Date: 2007-07-17

Last Posted Date: 2012-07-20

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 205

Registration Number: NCT00502502

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer

Phase 1

Completed

Conditions: Colorectal Cancer

Interventions: Drug: 5-FU
Drug: Cetuximab
Drug: Dasatinib
Drug: Leucovorin
Drug: Oxaliplatin

First Posted Date: 2007-07-16

Last Posted Date: 2019-08-28

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 86

Registration Number: NCT00501410

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Effect of Parathyroidectomy on Sleep

Not Applicable

Completed

Conditions: Hyperparathyroidism

Interventions: Procedure: Parathyroid Surgery
Behavioral: Telephone Interview
Behavioral: Polysomnography (PSG)

First Posted Date: 2007-07-16

Last Posted Date: 2017-07-18

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 15

Registration Number: NCT00501215

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy